| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/24/2001 | US6221353 The use of these proteins in vaccines or for the detection of tuberculosis. |
| 04/24/2001 | US6221352 Method of preventing the proliferation of Vβ14 or Vβ17-Expressing T cells |
| 04/24/2001 | US6221351 The enhancement of antitumor immunity and in the treatment of cancer in a tumor-bearing host. |
| 04/24/2001 | CA2176620C Hepatic growth factor receptor is the met proto-oncogene |
| 04/24/2001 | CA2135277C Anti-receptor agents to the vitamin b12/transcobalamin ii receptor |
| 04/24/2001 | CA2070659C Antibody preparation |
| 04/19/2001 | WO2001027335A1 A novel adjuvant |
| 04/19/2001 | WO2001027302A1 Recombinant, replication defective celo virus and celo virus dna |
| 04/19/2001 | WO2001027300A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/19/2001 | WO2001027295A1 Recombinant attenuated listerias for immunotherapy |
| 04/19/2001 | WO2001027294A1 Virus coat protein/receptor chimeras and methods of use |
| 04/19/2001 | WO2001027291A1 Design of a polyepitopic construct for the induction of hla-a2.1 restricted hiv 1 specific ctl responses using hhd mice |
| 04/19/2001 | WO2001027290A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | WO2001027282A1 Plant virus particles with exogenous internal eitopes |
| 04/19/2001 | WO2001027281A1 Designing immunogens |
| 04/19/2001 | WO2001027280A1 Antimicrobial compositions |
| 04/19/2001 | WO2001027276A2 Dna sequences from breast tumor and uses thereof |
| 04/19/2001 | WO2001027268A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | WO2001027265A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/19/2001 | WO2001027257A1 Tumor antigen derived gene-16 (tadg-16): a novel extracellular serine protease and uses thereof |
| 04/19/2001 | WO2001027255A2 Nucleic acid coding for a ctage gene family, use and production thereof |
| 04/19/2001 | WO2001027254A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | WO2001027144A2 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 04/19/2001 | WO2001026683A2 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 04/19/2001 | WO2001026682A2 Modified plant viruses and methods of use thereof |
| 04/19/2001 | WO2001026681A2 Method of obtaining cellular immune responses from proteins |
| 04/19/2001 | WO2001026680A2 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 04/19/2001 | WO2001026679A2 T-cells and molecules involved in immune regulation |
| 04/19/2001 | WO2001026672A1 Induction of a strong immune response to a self-tumor associated antigen |
| 04/19/2001 | WO2001026646A1 NUTRACEUTICAL PRODUCTS CONTAINING SAMe AND DIETARY SUPPLEMENTS AND METHOD OF MANUFACTURING AND USE THEREOF |
| 04/19/2001 | WO2001026608A2 Dna vaccines encoding antigen linked to a domain that binds cd40 |
| 04/19/2001 | WO2001026471A1 Pediculocidal and veterinary compositions |
| 04/19/2001 | WO2001026470A1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/19/2001 | WO2000076309A3 Non-human transgenic animals deficient in gas6 function and their use |
| 04/19/2001 | WO2000061132A8 Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft |
| 04/19/2001 | WO2000032047A9 Plasmid maintenance system for antigen delivery |
| 04/19/2001 | WO1999061913A3 Improvements in or relating to diagnosis and treatment of bacterial infections |
| 04/19/2001 | WO1999051188A3 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 04/19/2001 | DE19948417A1 Imidazol-Derivate und ihre Verwendung als Arzneimittel Imidazole derivatives and their use as medicaments |
| 04/19/2001 | CA2389652A1 Archaeosomes as immunomodulating carriers for acellular vaccines to induce cytotoxic t lymphocyte(ctl) responses and protect the vaccinated host against intracellular pathogens and cancer |
| 04/19/2001 | CA2388676A1 Method of obtaining cellular immune responses from proteins |
| 04/19/2001 | CA2387629A1 Modified plant viruses and methods of use thereof |
| 04/19/2001 | CA2387626A1 Viral particles with exogenous internal epitopes |
| 04/19/2001 | CA2387184A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | CA2387146A1 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | CA2387063A1 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 04/19/2001 | CA2385784A1 Antimicrobial compositions comprising multidrug efflux pumps |
| 04/19/2001 | CA2385196A1 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | CA2385186A1 Induction of a strong immune response to a self-tumor associated antigen |
| 04/19/2001 | CA2385172A1 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 04/19/2001 | CA2384805A1 Recombinant, replication defective celo virus and celo virus dna |
| 04/19/2001 | CA2382737A1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 04/18/2001 | EP1092780A1 Recombiant, replication defective CELO virus and CELO virus DNA |
| 04/18/2001 | EP1092779A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/18/2001 | EP1092774A2 Borrelia burgdorferi antigen OspA, gene encoding it and uses thereof |
| 04/18/2001 | EP1092772A1 Antibody against lar phosphatase subunit |
| 04/18/2001 | EP1092770A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/18/2001 | EP1092727A2 G-protein receptor |
| 04/18/2001 | EP1092439A1 Activation of antigen-specific T cells by virus/antigen-treated dendritic cells |
| 04/18/2001 | EP1092040A2 METHODS OF INHIBITING $i(HELICOBACTER PYLORI) |
| 04/18/2001 | EP1092031A2 Marburg virus vaccines |
| 04/18/2001 | EP1092030A2 Flt3-l mutants and methods of use |
| 04/18/2001 | EP1092028A1 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 04/18/2001 | EP1092027A1 Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same |
| 04/18/2001 | EP1092022A2 Immune system molecules |
| 04/18/2001 | EP1092018A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 04/18/2001 | EP1092013A1 3'-exonuclease, production and use thereof |
| 04/18/2001 | EP1091763A2 Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters |
| 04/18/2001 | EP1091757A2 Alpha emitting constructs and uses thereof |
| 04/18/2001 | EP1091756A2 Haemophilus parasuis vaccine and diagnostic |
| 04/18/2001 | EP1091755A1 Particulate delivery systems and methods of use |
| 04/18/2001 | EP1091751A1 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof |
| 04/18/2001 | EP1091735A1 Application for utility patent for improved enriched platelet wound healant |
| 04/18/2001 | EP0970126B1 Novel method for the production of antihuman antigen receptors and uses thereof |
| 04/18/2001 | EP0851872B1 Urogenital carcinoma tlp complex peptides and antibodies thereof |
| 04/18/2001 | EP0766566B1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 04/18/2001 | EP0576478B2 Herpes simplex vaccine comprising hsv glycoprotein gd and 3 deacylated monophosphoryl lipid a |
| 04/18/2001 | CN1292029A Compounds for therapy and diagnosis for lung cancer and method for their use |
| 04/18/2001 | CN1291899A Live recombined vaccines injected with adjuvant |
| 04/18/2001 | CN1291656A Nucleole antigenic monoantibody for esophagus cancer cell, reagent for diagnosing esophagus cancer, and its preparation |
| 04/18/2001 | CA2321437A1 Dna encoding structural protein-1 of infectious salmon anaemia virus and uses thereof |
| 04/17/2001 | US6218528 MurB |
| 04/17/2001 | US6218371 Administering immunopotentiating cytokine selected from group consisting of gm-csf, il-2, il-4 and ifn-.gamma., and immunostimulatory cpg oligonucleotide for inducing synergistic antigen specific immune response |
| 04/17/2001 | US6218166 Non-covalently incorporated adjuvant such as monophosphoryl lipid a (mpl) or a teichoic acid which stimulates an immune response; administering with cancer cells to treat cancer |
| 04/17/2001 | US6218159 Amino acid sequence; bacteriostats; bactericides; antibiotics; diagnosis of infections; drug screening |
| 04/17/2001 | US6218149 Altering affinity of antibody for antigen by deleting dna encoding a carbohydrate recognition site from variable domain of antibody, expressing mutagenized gene, measuring affinity of altered antibody and comparing to control |
| 04/17/2001 | US6218147 Haemophilus adhesin protein |
| 04/17/2001 | US6218141 Assembling expression vector using defined nucleotide sequence coding for protein, transforming host cell, then expressing, isolating, and purifying protein |
| 04/17/2001 | US6218102 Synthetic peptides and mixtures thereof for detecting HIV antibodies |
| 04/17/2001 | US6217900 Vesicular complexes and methods of making and using the same |
| 04/17/2001 | US6217884 Isolated, purified polypeptide |
| 04/17/2001 | US6217883 Immunology response |
| 04/17/2001 | US6217882 Inserting heterogeneity nucleotide sequence |
| 04/17/2001 | US6217881 Vaccine |
| 04/17/2001 | US6217880 Medicament for treating recurrent ulcer of mouth and behcet's syndrome |
| 04/17/2001 | US6217872 Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide |
| 04/17/2001 | US6217871 Generating an immune response to non-hodgkin lymphoma cell |
| 04/17/2001 | US6217870 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor |
| 04/17/2001 | US6217866 Antitumor agents mixture |